Bioventix PLC (AIM:BVXP)
London
· Delayed Price · Currency is GBP · Price in GBX 2,897.50
+47.50 (1.67%)
May 13, 2025, 12:26 PM GMT+1
Bioventix Market Cap
Bioventix has a market cap or net worth of 148.91 million as of May 13, 2025. Its market cap has decreased by -35.89% in one year.
Market Cap
148.91M
Enterprise Value
143.77M
Revenue
13.66M
Ranking
n/a
PE Ratio
19.24
Stock Price
2,897.50
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 148.91M, an increase of 1,412.15%. That is a compound annual growth rate of 19.71%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.79B |
| GSK plc | 55.98B |
| Haleon | 36.67B |
| Smith & Nephew | 9.35B |
| ConvaTec Group | 5.26B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.39B |